Arcutis Biotherapeutics (NASDAQ:ARQT) rose 12% amid some takeover speculation.
The biotech is speculated to have attracted some takeover interest, according to traders, who cited a Betaville "uncooked" alert that circulated on Wednesday. An unidentified European company is said to be interested.
https://seekingalpha.com/news/4407170-arcutis-biotherapeutics-jumps-amid-takeover-speculation
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.